DelveInsight Estimates a Promising Picture of JAK Inhibitors Clinical Trial Pipeline Landscape in the Coming Years as 40+ Key Pharma Players Bolster the Treatment Space

Source :: Plus Company Updates. November 16, 2022
Publication Year :: 2022
Abstract: LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's 'JAK Inhibitors Competitive Landscape - 2022' report provides comprehensive global coverage of available, marketed, and pipeline JAK [...]

Subjects :: United States. Food and Drug Administration -- Reports
Geron Corp. -- Forecasts and trends
Innoviva Inc. -- Forecasts and trends
Incyte Corp. -- Forecasts and trends
Biological products industry -- Forecasts and trends
Business -- Research
Biotechnology industry -- Forecasts and trends
Tofacitinib -- Forecasts and trends -- Reports
Clinical trials -- Forecasts and trends -- Reports
Pharmaceutical industry -- Forecasts and trends
Market trend/market analysis
General interest
News, opinion and commentary
Rinvoq (Medication) -- Reports

Tools